ABT-737

4-[4-[(4'-chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-Benzamide
852808-04-9

上海更新日期：2017-08-29

信实生物医药（上海）有限公司

非会员

联系人：Y***

电话：+86***

邮箱：adm***

产品详情:

中文名称：: ABT-737

英文名称：: 4-[4-[(4'-chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-Benzamide

CAS号：: 852808-04-9

Synthesis is established with a mission to provide drug discovery researchers with access to the world’s most up-to-date library of kinase and small molecule inhibitors for research use. Our founders include kinase scientists and expert synthetic chemists, and under their guidance we believe we have created the world's largest library of potent, pure and research-relevant kinase inhibitors for use as reference compounds.

成立日期	(18年)
注册资本	200万美元
员工人数	10-50人
年营业额	￥ 100万以内
经营模式	工厂,定制,服务
主营行业	原料药,有机合成药,心血管系统用药,中枢神经系统用药